{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:37:57Z","timestamp":1793381877006,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T00:00:00Z","timestamp":1565568000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T00:00:00Z","timestamp":1565568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1208\/s12249-019-1475-z","type":"journal-article","created":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T16:08:30Z","timestamp":1565626110000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Sericin Inhibits Devitrification of Amorphous Drugs"],"prefix":"10.1208","volume":"20","author":[{"given":"Nitin","family":"Salunkhe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namdeo","family":"Jadhav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harinath","family":"More","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prafulla","family":"Choudhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,12]]},"reference":[{"key":"1475_CR1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0939-6411(00)00076-X","volume":"50","author":"C Leuner","year":"2000","unstructured":"Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm. 2000;50:47\u201360. \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10840192\n                    \n                  .","journal-title":"Eur J Pharm Biopharm"},{"key":"1475_CR2","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1021\/js980403l","volume":"88","author":"ATM Serajuddln","year":"1999","unstructured":"Serajuddln ATM. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci. 1999;88:1058\u201366.","journal-title":"J Pharm Sci"},{"key":"1475_CR3","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/jps.10169","volume":"91","author":"D Zhou","year":"2002","unstructured":"Zhou D, Zhang GGZ, Law D, Grant DJW, Schmitt EA. Physical stability of amorphous pharmaceuticals: importance of configurational thermodynamic quantities and molecular mobility. J Pharm Sci. 2002;91:1863\u201372.","journal-title":"J Pharm Sci"},{"key":"1475_CR4","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ejps.2009.04.005","volume":"37","author":"KA Graeser","year":"2009","unstructured":"Graeser KA, Patterson JE, Zeitler JA, Gordon KC, Rades T. Correlating thermodynamic and kinetic parameters with amorphous stability. Eur J Pharm Sci. 2009;37:492\u20138.","journal-title":"Eur J Pharm Sci"},{"key":"1475_CR5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0378-5173(90)90221-O","volume":"62","author":"C Ahlneck","year":"1990","unstructured":"Ahlneck C, Zografi G. The molecular basis of moisture effects on the physical and chemical stability of drugs in the solid state. Int J Pharm. 1990;62:87\u201395.","journal-title":"Int J Pharm"},{"key":"1475_CR6","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/jps.2600831211","volume":"83","author":"M Yoshioka","year":"1994","unstructured":"Yoshioka M, Hancock BC, Zografi G. Crystallization of lndomethacin from the amorphous state below and above its glass transition temperature. J Pharm Sci. 1994;83:1700\u20135.","journal-title":"J Pharm Sci"},{"key":"1475_CR7","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1007\/s11095-017-2221-4","volume":"34","author":"NS Trasi","year":"2017","unstructured":"Trasi NS, Purohit HS, Taylor LS. Evaluation of the crystallization tendency of commercially available amorphous tacrolimus formulations exposed to different stress conditions. Pharm Res. 2017;34:2142\u201355.","journal-title":"Pharm Res"},{"issue":"9","key":"1475_CR8","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1016\/j.xphs.2015.10.008","volume":"105","author":"Shrawan Baghel","year":"2016","unstructured":"Baghel S, Cathcart H, O\u2019Reilly NJ. Polymeric amorphous solid dispersions: a review of amorphization, crystallization, stabilization, solid-state characterization, and aqueous solubilization of biopharmaceutical classification system class II drugs. J Pharm Sci Elsevier Ltd. 2016;105:2527\u201344. Available from: \n                    https:\/\/doi.org\/10.1016\/j.xphs.2015.10.008\n                    \n                  .","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"1475_CR9","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1023\/A:1016292416526","volume":"12","author":"B Hancock","year":"1995","unstructured":"Hancock B, Shamblin S, Zografi G. Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures. Pharm Res. 1995;12:799\u2013806.","journal-title":"Pharm Res"},{"key":"1475_CR10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.powtec.2006.05.012","volume":"167","author":"VB Pokharkar","year":"2006","unstructured":"Pokharkar VB, Mandpe LP, Padamwar MN, Ambike AA, Mahadik KR, Paradkar A. Development, characterization and stabilization of amorphous form of a low Tg drug. Powder Technol. 2006;167:20\u20135.","journal-title":"Powder Technol"},{"key":"1475_CR11","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1023\/A:1018906132279","volume":"16","author":"T Matsumoto","year":"1999","unstructured":"Matsumoto T, Zografi G. Physical properties of solid molecular dispersions of indomethacin with poly (vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization. Pharm Res. 1999;16:1722\u20138.","journal-title":"Pharm Res"},{"key":"1475_CR12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1081\/DDC-120030421","volume":"30","author":"R Pignatello","year":"2004","unstructured":"Pignatello R, Spadaro D, Vandelli MA, Forni F, Puglisi G. Characterization of the mechanism of interaction in ibuprofen-Eudragit RL100 coevaporates. Drug Dev Ind Pharm. 2004;30:277\u201388. \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15109027\n                    \n                  .","journal-title":"Drug Dev Ind Pharm"},{"key":"1475_CR13","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s10973-006-7958-7","volume":"89","author":"TP Shakhtshneider","year":"2007","unstructured":"Shakhtshneider TP, De FD\u00c0, Capet F, Willart JF, Descamps M, S a M, et al. Grinding of drugs with pharmaceutical excipients at cryogenic temperatures part I. Cryogenic grinding of piroxicam \u2013 polyvinylpyrrolidone mixtures. J Therm Anal Calorim. 2007;89:699\u2013707.","journal-title":"J Therm Anal Calorim"},{"key":"1475_CR14","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s10973-006-7959-6","volume":"89","author":"TP Shakhtshneider","year":"2007","unstructured":"Shakhtshneider TP, Dan\u00e8de F, Capet F, Willart JF, Descamps M, Paccou L, et al. Grinding of drugs with pharmaceutical excipients at cryogenic temperatures. J Therm Anal Calorim. 2007;89:709\u201315.","journal-title":"J Therm Anal Calorim"},{"key":"1475_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.powtec.2012.02.020","volume":"222","author":"Snehal P. Mulye","year":"2012","unstructured":"Mulye SP, Jamadar SA, Karekar PS, Pore YV, Dhawale SC. Improvement in physicochemical properties of ezetimibe using a crystal engineering technique. Powder Technol Elsevier BV. 2012;222:131\u20138. Available from: \n                    https:\/\/doi.org\/10.1016\/j.powtec.2012.02.020\n                    \n                  .","journal-title":"Powder Technology"},{"key":"1475_CR16","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.powtec.2016.06.032","volume":"301","author":"Q Fu","year":"2016","unstructured":"Fu Q, Fang M, Hou Y, Yang W, Shao J, Guo M, et al. A physically stabilized amorphous solid dispersion of nisoldipine obtained by hot melt extrusion. Powder Technol. 2016;301:342\u20138.","journal-title":"Powder Technol"},{"key":"1475_CR17","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1208\/s12249-012-9755-x","volume":"13","author":"S Bhende","year":"2012","unstructured":"Bhende S, Jadhav N. Moringa coagulant as a stabilizer for amorphous solids: part I. AAPS PharmSciTech. 2012;13:400\u201310. \n                    http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3364398&tool=pmcentrez&rendertype=abstract\n                    \n                  .","journal-title":"AAPS PharmSciTech"},{"key":"1475_CR18","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s11095-017-2173-8","volume":"34","author":"D Shilpi","year":"2017","unstructured":"Shilpi D, Kushwah V, Agrawal AK, Jain S. Improved stability and enhanced oral bioavailability of atorvastatin loaded stearic acid modified gelatin nanoparticles. Pharm Res. 2017;34:1505\u201316.","journal-title":"Pharm Res"},{"key":"1475_CR19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0928-0987(00)00173-1","volume":"12","author":"G Van den Mooter","year":"2001","unstructured":"Van den Mooter G, Wuyts M, Blaton N, Busson R, Grobet P, Augustijns P, et al. Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. Eur J Pharm Sci. 2001;12:261\u20139.","journal-title":"Eur J Pharm Sci"},{"key":"1475_CR20","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1002\/jps.24410","volume":"104","author":"MM Knopp","year":"2015","unstructured":"Knopp MM, Olesen NE, Holm P, Langguth P, Holm R, Rades T. Influence of polymer molecular weight on drug-polymer solubility: a comparison between experimentally determined solubility in PVP and prediction derived from solubility in monomer. J Pharm Sci. 2015;104:2905\u201312.","journal-title":"J Pharm Sci"},{"issue":"1-2","key":"1475_CR21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijpharm.2014.06.025","volume":"472","author":"Peng Zhang","year":"2014","unstructured":"Zhang P, Forsgren J, Str\u00f8mme M. Stabilisation of amorphous ibuprofen in Upsalite, a mesoporous magnesium carbonate, as an approach to increasing the aqueous solubility of poorly soluble drugs. Int J Pharm Elsevier BV. 2014;472:185\u201391. Available from: \n                    https:\/\/doi.org\/10.1016\/j.ijpharm.2014.06.025\n                    \n                  .","journal-title":"International Journal of Pharmaceutics"},{"key":"1475_CR22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0928-0987(94)90040-X","volume":"1","author":"S Lin","year":"1994","unstructured":"Lin S, Cheng C. Solid state interaction studies of drug-polymers (II): warfarin-Eudragit E, RL or S resins Shan-Yang. Eur J Pharm Sci. 1994;1:313\u201322.","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"1475_CR23","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ijpharm.2010.01.039","volume":"390","author":"Heike Bley","year":"2010","unstructured":"Bley H, Fussnegger B, Bodmeier R. Characterization and stability of solid dispersions based on PEG\/polymer blends. Int J Pharm Elsevier BV. 2010;390:165\u201373. Available from: \n                    https:\/\/doi.org\/10.1016\/j.ijpharm.2010.01.039\n                    \n                  .","journal-title":"International Journal of Pharmaceutics"},{"key":"1475_CR24","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1002\/jps.24008","volume":"103","author":"DM Vasa","year":"2014","unstructured":"Vasa DM, Dalal N, Katz JM, Roopwani R, Nevrekar A, Patel H, et al. Physical characterization of drug: polymer dispersion behavior in polyethylene glycol 4000 solid dispersions using a suite of complementary analytical techniques. J Pharm Sci. 2014;103:2911\u201323.","journal-title":"J Pharm Sci"},{"issue":"9","key":"1475_CR25","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1002\/jps.24023","volume":"103","author":"Hiroshi Ueda","year":"2014","unstructured":"Ueda H, Aikawa S, Kashima Y, Kikuchi J, Ida Y, Tanino T, et al. Anti-plasticizing effect of amorphous indomethacin induced by specific intermolecular interactions with PVA copolymer. J Pharm Sci Elsevier Masson SAS. 2014;103:2829\u201338. Available from: \n                    https:\/\/doi.org\/10.1002\/jps.24023\n                    \n                  .","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"1475_CR26","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11095-005-6694-1","volume":"22","author":"SL Shimpi","year":"2005","unstructured":"Shimpi SL, Chauhan B, Mahadik KR, Paradkar A. Stabilization and improved in vivo performance of amorphous etoricoxib using Gelucire 50\/13. Pharm Res. 2005;22:1727\u201334.","journal-title":"Pharm Res"},{"key":"1475_CR27","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.carbpol.2014.06.039","volume":"112","author":"Ashish L. Sarode","year":"2014","unstructured":"Sarode AL, Malekar SA, Cote C, Worthen DR. Hydroxypropyl cellulose stabilizes amorphous solid dispersions of the poorly water soluble drug felodipine. Carbohydr Polym Elsevier Ltd. 2014;112:512\u20139. Available from: \n                    https:\/\/doi.org\/10.1016\/j.carbpol.2014.06.039\n                    \n                  .","journal-title":"Carbohydrate Polymers"},{"key":"1475_CR28","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1002\/jps.20697","volume":"95","author":"H Konno","year":"2006","unstructured":"Konno H, Taylor LS. Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine. J Pharm Sci. 2006;95:2692\u2013705.","journal-title":"J Pharm Sci"},{"key":"1475_CR29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.apsb.2013.06.007","volume":"3","author":"J Liu","year":"2013","unstructured":"Liu J, Cao F, Zhang C, Ping Q. Use of polymer combinations in the preparation of solid dispersions of a thermally unstable drug by hot-melt extrusion. Acta Pharm Sin B. 2013;3:263\u201372. \n                    http:\/\/www.sciencedirect.com\/science\/article\/pii\/S2211383513000646\n                    \n                  .","journal-title":"Acta Pharm Sin B"},{"key":"1475_CR30","first-page":"198","volume":"21","author":"P Aramwit","year":"2009","unstructured":"Aramwit P. Effectiveness of inflammatory cytokines induced by sericin compared to sericin in combination with silver sulfadiazine cream on wound healing. Wounds. 2009;21:198\u2013206.","journal-title":"Wounds."},{"key":"1475_CR31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1471-2369-13-119","volume":"13","author":"P Aramwit","year":"2012","unstructured":"Aramwit P, Keongamaroon O, Siritientong T, Bang N, Supasyndh O. Sericin cream reduces pruritus in hemodialysis patients: a randomized, double-blind, placebo-controlled experimental study. BMC Nephrol. 2012;13:119. \n                    http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3472272&tool=pmcentrez&rendertype=abstract\n                    \n                  .","journal-title":"BMC Nephrol"},{"key":"1475_CR32","first-page":"54","volume":"5","author":"T Kitisin","year":"2013","unstructured":"Kitisin T, Maneekan P, Luplertlop N. In-vitro characterization of silk sericin as an anti-aging agent. J Agric Sci. 2013;5:54\u201363.","journal-title":"J Agric Sci"},{"key":"1475_CR33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1011-1344(03)00092-7","volume":"71","author":"S Zhaorigetu","year":"2003","unstructured":"Zhaorigetu S, Yanaka N, Sasaki M, Watanabe H, Kato N. Inhibitory effects of silk protein, sericin on UVB-induced acute damage and tumor promotion by reducing oxidative stress in the skin of hairless mouse. J Photochem Photobiol B Biol. 2003;71:11\u20137.","journal-title":"J Photochem Photobiol B Biol"},{"key":"1475_CR34","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1271\/bbb.66.2715","volume":"66","author":"Y Takasu","year":"2002","unstructured":"Takasu Y, Yamada H, Tsubouchi K. Isolation of three main sericin components from the cocoon of the silkworm, Bombyx mori. Biosci Biotechnol Biochem. 2002;66:2715\u20138.","journal-title":"Biosci Biotechnol Biochem"},{"key":"1475_CR35","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/mame.200400306","volume":"290","author":"W Tao","year":"2005","unstructured":"Tao W, Li M, Xie R. Preparation and structure of porous silk sericin materials. Macromol Mater Eng. 2005;290:188\u201394.","journal-title":"Macromol Mater Eng"},{"key":"1475_CR36","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/0734242X11404733","volume":"30","author":"P Aramwit","year":"2012","unstructured":"Aramwit P, Siritientong T, Srichana T. Potential applications of silk sericin, a natural protein from textile industry by-products. Waste Manag Res. 2012;30:217\u201324. \n                    http:\/\/www.researchgate.net\/publication\/51113185_Potential_applications_of_silk_sericin_a_natural_protein_from_textile_industry_by-products\n                    \n                  .","journal-title":"Waste Manag Res"},{"key":"1475_CR37","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00534-009-0049-y","volume":"16","author":"M Morikawa","year":"2009","unstructured":"Morikawa M, Kimura T, Murakami M, Katayama K, Terada S, Yamaguchi A. Rat islet culture in serum-free medium containing silk protein sericin. J Hepato-Biliary-Pancreat Surg. 2009;16:223\u20138.","journal-title":"J Hepato-Biliary-Pancreat Surg"},{"key":"1475_CR38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1023\/A:1023993400608","volume":"40","author":"S Terada","year":"2003","unstructured":"Terada S, Nishimura T, Sasaki M, Yamada H, Miki M. Sericin, a protein derived from silkworms, accelerates the proliferation of several mammalian cell lines including a hybridoma. Cytotechnology. 2003;40:3\u201312.","journal-title":"Cytotechnology."},{"key":"1475_CR39","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/oxfordjournals.jbchem.a002946","volume":"986","author":"K Tsujimoto","year":"2001","unstructured":"Tsujimoto K, Takagi H, Takahashi M, Yamada H, Nakamori S, Tagaki H, et al. Cryoprotective effect of the serine-rich repetitive sequence in silk protein sericin. J Biochem. 2001;986:979\u201386.","journal-title":"J Biochem"},{"key":"1475_CR40","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/j.ijbiomac.2017.10.035","volume":"107","author":"NH Salunkhe","year":"2018","unstructured":"Salunkhe NH, Jadhav NR, More HN, Jadhav AD. Screening of drug-sericin solid dispersions for improved solubility and dissolution. Int J Biol Macromol Elsevier BV. 2018;107:1683\u201391. Available from. \n                    https:\/\/doi.org\/10.1016\/j.ijbiomac.2017.10.035\n                    \n                  .","journal-title":"Int J Biol Macromol Elsevier BV"},{"key":"1475_CR41","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0734-9750(02)00003-4","volume":"20","author":"YQ Zhang","year":"2002","unstructured":"Zhang YQ. Applications of natural silk protein sericin in biomaterials. Biotechnol Adv. 2002;20:91\u2013100.","journal-title":"Biotechnol Adv"},{"key":"1475_CR42","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ijpharm.2006.11.029","volume":"336","author":"CF Rawlinson","year":"2007","unstructured":"Rawlinson CF, Williams AC, Timmins P, Grimsey I. Polymer-mediated disruption of drug crystallinity. Int J Pharm. 2007;336:42\u20138.","journal-title":"Int J Pharm"},{"issue":"2","key":"1475_CR43","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.arabjc.2016.09.024","volume":"10","author":"S.A. Deodware","year":"2017","unstructured":"Deodware SA, Sathe DJ, Choudhari PB, Lokhande TN, Gaikwad SH. Development and molecular modeling of Co(II), Ni(II) and Cu(II) complexes as high acting anti breast cancer agents. Arab J Chem The Authors. 2017;10:262\u201372. Available from: \n                    https:\/\/doi.org\/10.1016\/j.arabjc.2016.09.024\n                    \n                  .","journal-title":"Arabian Journal of Chemistry"},{"issue":"11","key":"1475_CR44","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1007\/s00044-017-1988-5","volume":"26","author":"Yogita K. Abhale","year":"2017","unstructured":"Abhale YK, Shinde AD, Deshmukh KK, Nawale L, Sarkar D, Choudhari PB, et al. Synthesis, antimycobacterial screening and molecular docking studies of 4-aryl-4\u2032-methyl-2\u2032-aryl-2,5\u2032-bisthiazole derivatives. Med Chem Res Springer US. 2017;26:1\u201311. Available from: \n                    https:\/\/doi.org\/10.1007\/s00044-017-1988-5\n                    \n                  .","journal-title":"Medicinal Chemistry Research"},{"key":"1475_CR45","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jtice.2016.09.034","volume":"68","author":"Ajinkya A. Patravale","year":"2016","unstructured":"Patravale AA, Gore AH, Kolekar GB, Deshmukh MB, Choudhari PB, Bhatia MS, et al. Synthesis, biological evaluation and molecular docking studies of some novel indenospiro derivatives as anticancer agents. J Taiwan Inst Chem Eng Elsevier BV. 2016;68:105\u201318. Available from: \n                    https:\/\/doi.org\/10.1016\/j.jtice.2016.09.034\n                    \n                  .","journal-title":"Journal of the Taiwan Institute of Chemical Engineers"},{"key":"1475_CR46","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/jps.20794","volume":"96","author":"YFM Shibata","year":"2007","unstructured":"Shibata YFM, Kokudai M, Noda S, Okada H, Kondoh M, Watanabe Y. Effect of characteristics of compounds on maintenance of an amorphous state in solid dispersion with crospovidone. J Pharm Sci. 2007;96:1537\u201347.","journal-title":"J Pharm Sci"},{"issue":"1","key":"1475_CR47","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ejpb.2008.06.001","volume":"71","author":"M SAVOLAINEN","year":"2009","unstructured":"Savolainen M, Kogermann K, Heinz A, Aaltonen J, Peltonen L, Strachan C, et al. Better understanding of dissolution behaviour of amorphous drugs by in situ solid-state analysis using Raman spectroscopy. Eur J Pharm Biopharm Elsevier BV. 2009;71:71\u20139. Available from: \n                    https:\/\/doi.org\/10.1016\/j.ejpb.2008.06.001\n                    \n                  .","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"1475_CR48","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/B978-0-12-387667-6.00006-3","volume-title":"Profiles of Drug Substances, Excipients and Related Methodology","author":"Mahrous O. Ahmed","year":"2011","unstructured":"Ahmed MO, Al-Badr AA. Lornoxicam. 1st ed. profiles drug Subst. Excipients Relat. Methodol. Elsevier Inc.; 2011. Available from: \n                    https:\/\/doi.org\/10.1016\/B978-0-12-387667-6.00006-3\n                    \n                  ."},{"key":"1475_CR49","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/jps.22760","volume":"101","author":"S Ozaki","year":"2012","unstructured":"Ozaki S, Minamisono T, Yamashita T, Kato T, Kushida I. Supersaturation\u2013nucleation behavior of poorly soluble drugs and its impact on the oral absorption of drugs in thermodynamically high-energy forms. J Pharm Sci. 2012;101:214\u201322.","journal-title":"J Pharm Sci"},{"key":"1475_CR50","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1002\/jps.23306","volume":"101","author":"S Ozaki","year":"2012","unstructured":"Ozaki S, Kushida I, Yamashita T, Hasebe T, Shirai O, Kano K. Evaluation of drug supersaturation by thermodynamic and kinetic approaches for the prediction of oral absorbability in amorphous pharmaceuticals. J Pharm Sci. 2012;101:4220\u201330.","journal-title":"J Pharm Sci"},{"key":"1475_CR51","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1002\/jps.23588","volume":"102","author":"S Ozaki","year":"2013","unstructured":"Ozaki S, Kushida I, Yamashita T, Hasebe T, Shirai O, Kano K. Inhibition of crystal nucleation and growth by water-soluble polymers and its impact on the supersaturation profiles of amorphous drugs. J Pharm Sci. 2013;102:2273\u201381.","journal-title":"J Pharm Sci"},{"key":"1475_CR52","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jconrel.2019.01.039","volume":"298","author":"S Saboo","year":"2019","unstructured":"Saboo S, Mugheirbi NA, Zemlyanov DY, Kestur US, Taylor LS. Congruent release of drug and polymer: a \u201csweet spot\u201d in the dissolution of amorphous solid dispersions. J Control Release Elsevier BV. 2019;298:68\u201382. Available from. \n                    https:\/\/doi.org\/10.1016\/j.jconrel.2019.01.039\n                    \n                  .","journal-title":"J Control Release Elsevier BV"},{"key":"1475_CR53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2003.11.025","volume":"272","author":"S Sethia","year":"2004","unstructured":"Sethia S, Squillante E. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int J Pharm. 2004;272:1\u201310.","journal-title":"Int J Pharm"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-019-1475-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-019-1475-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-019-1475-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T23:06:01Z","timestamp":1597100761000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-019-1475-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,12]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["1475"],"URL":"https:\/\/doi.org\/10.1208\/s12249-019-1475-z","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,12]]},"assertion":[{"value":"8 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"285"}}